Skip to content
10-Q

Quarterly Report

CHEMBIO DIAGNOSTICS, INC.

0001140361-22-039883

← back to feed
Filed
Nov 3, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Oct 24, 2022 36.71M sh
Shares Diluted Q3 2022 · Sep 30, 2022 32.27M sh
Shares Diluted Q3 2022 · Sep 30, 2022 30.86M sh
Shares Diluted Q3 2022 · Sep 30, 2021 26.7M sh
Shares Diluted Q3 2022 · Sep 30, 2021 22.36M sh
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$9.86M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$24.15M
Short Term Debt Q3 2022 · Sep 30, 2022 $18.99M
Short Term Debt Q3 2022 · Dec 31, 2021 $1.2M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $21.06M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $28.77M
Stockholders Equity Q3 2022 · Sep 30, 2022 $17.79M
Stockholders Equity Q3 2022 · Jun 30, 2022 $19.9M
Stockholders Equity Q3 2022 · Mar 31, 2022 $26.54M
Stockholders Equity Q3 2022 · Dec 31, 2021 $34.26M
Stockholders Equity Q3 2022 · Sep 30, 2021 $47.92M
Stockholders Equity Q3 2022 · Jun 30, 2021 $15.1M
Stockholders Equity Q3 2022 · Mar 31, 2021 $23.29M
Stockholders Equity Q3 2022 · Dec 31, 2020 $27.78M
Current Liabilities Q3 2022 · Sep 30, 2022 $38.62M
Current Liabilities Q3 2022 · Dec 31, 2021 $15.28M
Total Liabilities Q3 2022 · Sep 30, 2022 $44.39M
Total Liabilities Q3 2022 · Dec 31, 2021 $38.99M
Current Assets Q3 2022 · Sep 30, 2022 $47.28M
Current Assets Q3 2022 · Dec 31, 2021 $55.23M
Total Assets Q3 2022 · Sep 30, 2022 $62.18M
Total Assets Q3 2022 · Dec 31, 2021 $73.25M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.21
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.73
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.24
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.89
Eps Basic Q3 2022 · Sep 30, 2022 −$0.21
Eps Basic Q3 2022 · Sep 30, 2022 −$0.73
Eps Basic Q3 2022 · Sep 30, 2021 −$0.24
Eps Basic Q3 2022 · Sep 30, 2021 −$0.89
Sga Expense Q3 2022 · Sep 30, 2022 $5.55M
Sga Expense Q3 2022 · Sep 30, 2022 $17.75M
Sga Expense Q3 2022 · Sep 30, 2021 $5.95M
Sga Expense Q3 2022 · Sep 30, 2021 $18.03M
Rd Expense Q3 2022 · Sep 30, 2022 $1.87M
Rd Expense Q3 2022 · Sep 30, 2022 $5.57M
Rd Expense Q3 2022 · Sep 30, 2021 $3.44M
Rd Expense Q3 2022 · Sep 30, 2021 $9.1M
Net Income Q3 2022 · Sep 30, 2022 −$6.7M
Net Income Q3 2022 · Sep 30, 2022 −$22.44M
Net Income Q3 2022 · Jun 30, 2022 −$6.95M
Net Income Q3 2022 · Mar 31, 2022 −$8.79M
Net Income Q3 2022 · Sep 30, 2021 −$6.37M
Net Income Q3 2022 · Sep 30, 2021 −$19.93M
Net Income Q3 2022 · Jun 30, 2021 −$9.06M
Net Income Q3 2022 · Mar 31, 2021 −$4.5M
Operating Income Q3 2022 · Sep 30, 2022 −$5.99M
Operating Income Q3 2022 · Sep 30, 2022 −$20.26M
Operating Income Q3 2022 · Sep 30, 2021 −$5.63M
Operating Income Q3 2022 · Sep 30, 2021 −$17.82M
Cost Of Revenue Q3 2022 · Sep 30, 2022 $9.66M
Cost Of Revenue Q3 2022 · Sep 30, 2022 $32.97M
Cost Of Revenue Q3 2022 · Sep 30, 2021 $7.9M
Cost Of Revenue Q3 2022 · Sep 30, 2021 $15.49M
Revenue Q3 2022 · Sep 30, 2022 $11.2M
Revenue Q3 2022 · Sep 30, 2022 $39.18M
Revenue Q3 2022 · Sep 30, 2021 $12.06M
Revenue Q3 2022 · Sep 30, 2021 $27.24M